Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Brunelli

Showing results (121-130 of 409) with videos related to

Pageof 41
Sort By:
Histology and Histopathology|September 29, 2012
Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspectsNaoto Kuroda, Azusa Tanaka, Chisato Ohe, et al.
Cancer Treatment Reviews|February 2, 2016
AR-V7 and prostate cancer: The watershed for treatment selection?Chiara Ciccarese, Matteo Santoni, Matteo Brunelli, et al.
Histopathology|December 21, 2010
Suitability of infiltrative lobular breast carcinoma for anti-human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meetingMarco Vergine, Matteo Brunelli, Guido Martignoni, et al.
Current Pharmaceutical Design|October 22, 2013
Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'Sara Pilotto, Maria Bonomi, Francesco Massari, et al.
Endocrine Pathology|May 30, 2020
Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid CarcinomaIlaria Girolami, Liron Pantanowitz, Ozgur Mete, et al.
The American Journal of Surgical Pathology|July 3, 2008
Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entityStefano Gobbo, John N Eble, David J Grignon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2004
Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumorsKevin M Kernek, Matteo Brunelli, Thomas M Ulbright, et al.
The American Journal of Surgical Pathology|September 10, 2008
Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosisStefano Gobbo, John N Eble, Gregory T Maclennan, et al.
Journal of Cutaneous Pathology|June 12, 2009
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literatureMatteo Brunelli, Erminia Manfrin, Keith Miller, et al.
Anti-Cancer Drugs|January 9, 2015
Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacyFrancesco Massari, Chiara Ciccarese, Davide Bimbatti, et al.
Pageof 41

Showing results (121-130 of 409) with videos related to

Sort By:
Pageof 41
Histology and Histopathology|September 29, 2012
Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspectsNaoto Kuroda, Azusa Tanaka, Chisato Ohe, et al.
Cancer Treatment Reviews|February 2, 2016
AR-V7 and prostate cancer: The watershed for treatment selection?Chiara Ciccarese, Matteo Santoni, Matteo Brunelli, et al.
Histopathology|December 21, 2010
Suitability of infiltrative lobular breast carcinoma for anti-human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meetingMarco Vergine, Matteo Brunelli, Guido Martignoni, et al.
Current Pharmaceutical Design|October 22, 2013
Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'Sara Pilotto, Maria Bonomi, Francesco Massari, et al.
Endocrine Pathology|May 30, 2020
Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid CarcinomaIlaria Girolami, Liron Pantanowitz, Ozgur Mete, et al.
The American Journal of Surgical Pathology|July 3, 2008
Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entityStefano Gobbo, John N Eble, David J Grignon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2004
Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumorsKevin M Kernek, Matteo Brunelli, Thomas M Ulbright, et al.
The American Journal of Surgical Pathology|September 10, 2008
Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosisStefano Gobbo, John N Eble, Gregory T Maclennan, et al.
Journal of Cutaneous Pathology|June 12, 2009
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literatureMatteo Brunelli, Erminia Manfrin, Keith Miller, et al.
Anti-Cancer Drugs|January 9, 2015
Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacyFrancesco Massari, Chiara Ciccarese, Davide Bimbatti, et al.
Pageof 41